Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
RICH
MCID: RPD005
MIFTS: 38

Rapidly Involuting Congenital Hemangioma (RICH)

Categories: Cardiovascular diseases, Fetal diseases, Rare diseases
Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Rapidly Involuting Congenital Hemangioma

About this section

MalaCards integrated aliases for Rapidly Involuting Congenital Hemangioma:

Name: Rapidly Involuting Congenital Hemangioma 58
Rich 58

Characteristics:

Orphanet epidemiological data:

58
rapidly involuting congenital hemangioma
Inheritance: Not applicable; Age of onset: Infancy,Neonatal;

Classifications:

MalaCards categories:
Global: Fetal diseases Rare diseases
Anatomical: Cardiovascular diseases
See all MalaCards categories (disease lists)
ICD10: 33
Orphanet: 58  
Rare circulatory system diseases
Developmental anomalies during embryogenesis


External Ids:

ICD10 via Orphanet 33 D18.0
UMLS via Orphanet 72 C1275421
Orphanet 58 ORPHA141184
Sources

Summaries for Rapidly Involuting Congenital Hemangioma

About this section
MalaCards based summary : Rapidly Involuting Congenital Hemangioma, also known as rich, is related to hemangioma and congenital hemangioma. The drugs Hyaluronic acid and Insulin aspart have been mentioned in the context of this disorder. Affiliated tissues include bone, liver and breast, and related phenotypes are telangiectasia of the skin and subcutaneous calcification

Wikipedia : 74 A vascular tumor is a tumor of vascular origin; a soft tissue growth that can be either benign or... more...

Sources

Related Diseases for Rapidly Involuting Congenital Hemangioma

About this section

Diseases related to Rapidly Involuting Congenital Hemangioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 19)
# Related Disease Score Top Affiliating Genes
1 hemangioma 10.8
2 congenital hemangioma 10.8
3 non-involuting congenital hemangioma 10.5
4 arteriovenous malformation 10.2
5 thrombocytopenia 10.2
6 posttransplant acute limbic encephalitis 10.2
7 rare tumor 10.2
8 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.1
9 angioma, tufted 10.1
10 deficiency anemia 10.1
11 telangiectasis 10.1
12 vascular cancer 10.1
13 teratoma 10.1
14 fibrosarcoma 10.1
15 congenital fibrosarcoma 10.1
16 cleft lip 10.1
17 hemangioendothelioma 10.1
18 kaposiform hemangioendothelioma 10.1
19 rare vascular tumor 10.1

Graphical network of the top 20 diseases related to Rapidly Involuting Congenital Hemangioma:



Diseases related to Rapidly Involuting Congenital Hemangioma
Sources

Symptoms & Phenotypes for Rapidly Involuting Congenital Hemangioma

About this section

Human phenotypes related to Rapidly Involuting Congenital Hemangioma:

58 31 (show all 14)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 telangiectasia of the skin 58 31 frequent (33%) Frequent (79-30%) HP:0100585
2 subcutaneous calcification 58 31 frequent (33%) Frequent (79-30%) HP:0007618
3 midfrontal capillary hemangioma 58 31 frequent (33%) Frequent (79-30%) HP:0007466
4 perineal hemangioma 58 31 frequent (33%) Frequent (79-30%) HP:0031449
5 congestive heart failure 58 31 occasional (7.5%) Occasional (29-5%) HP:0001635
6 thrombocytopenia 58 31 occasional (7.5%) Occasional (29-5%) HP:0001873
7 peripheral arteriovenous fistula 58 31 occasional (7.5%) Occasional (29-5%) HP:0100784
8 prominent superficial veins 58 31 occasional (7.5%) Occasional (29-5%) HP:0001015
9 avascular necrosis 58 31 very rare (1%) Very rare (<4-1%) HP:0010885
10 lipoatrophy 58 31 very rare (1%) Very rare (<4-1%) HP:0100578
11 hepatic hemangioma 58 31 very rare (1%) Very rare (<4-1%) HP:0031207
12 hemangioma 58 Obligate (100%)
13 visceral hemangioma 58 Occasional (29-5%)
14 tufted angioma 58 Excluded (0%)
Sources

Drugs & Therapeutics for Rapidly Involuting Congenital Hemangioma

About this section

Drugs for Rapidly Involuting Congenital Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 930)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741
2
Insulin aspart Approved Phase 4 116094-23-6 16132418
3
Parathyroid hormone Approved, Investigational Phase 4 9002-64-6
4
Asenapine Approved Phase 4 65576-45-6, 85650-56-2 3001386
5
Lactulose Approved Phase 4 4618-18-2 11333
6
Insulin glulisine Approved Phase 4 207748-29-6
7
Insulin lispro Approved Phase 4 133107-64-9
8
Linagliptin Approved Phase 4 668270-12-0 10096344
9
Cimetidine Approved, Investigational Phase 4 51481-61-9 2756
10
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
11
leucovorin Approved Phase 4 58-05-9 6006 143
12
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
13
Simvastatin Approved Phase 4 79902-63-9 54454
14
Lactitol Approved, Investigational Phase 4 585-88-6, 585-86-4 493591
15
Magnesium citrate Approved Phase 4 3344-18-1
16
Potassium citrate Approved, Investigational, Vet_approved Phase 4 866-84-2
17
Primaquine Approved Phase 4 90-34-6 4908
18
Artesunate Approved, Investigational Phase 4 88495-63-0 6917864 5464098
19 Artichoke Approved Phase 4
20
Dimenhydrinate Approved Phase 4 523-87-5 441281
21
Ezetimibe Approved Phase 4 163222-33-1 150311
22
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
23
Metronidazole Approved Phase 4 443-48-1 4173
24
Flurbiprofen Approved, Investigational Phase 4 5104-49-4 3394
25
Pentazocine Approved, Vet_approved Phase 4 359-83-1 441278
26
Palonosetron Approved, Investigational Phase 4 135729-56-5, 119904-90-4 148211
27
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
28
Lixisenatide Approved Phase 4 320367-13-3
29
Allopurinol Approved Phase 4 315-30-0 2094
30
Ribavirin Approved Phase 4 36791-04-5 37542
31
Peginterferon alfa-2b Approved Phase 4 99210-65-8, 215647-85-1
32
Histamine Approved, Investigational Phase 4 51-45-6 774
33
Amodiaquine Approved, Investigational Phase 4 86-42-0 2165
34
Ferrous succinate Approved Phase 4 10030-90-7
35
Cilostazol Approved, Investigational Phase 4 73963-72-1 2754
36
Xylometazoline Approved, Investigational Phase 4 526-36-3 5709
37
Glimepiride Approved Phase 4 93479-97-1 3476
38
Sulfadoxine Approved, Investigational Phase 4 2447-57-6 17134
39
Pyrimethamine Approved, Investigational, Vet_approved Phase 4 58-14-0 4993
40
Atorvastatin Approved Phase 4 134523-00-5 60823
41
Lenograstim Approved, Investigational Phase 4 135968-09-1
42
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
43
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 9552079 2713
44
Furosemide Approved, Vet_approved Phase 4 54-31-9 3440
45
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
46
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
47
Probucol Approved, Investigational Phase 4 23288-49-5 4912
48
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
49
Mannitol Approved, Investigational Phase 4 69-65-8 6251 453
50
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821

Interventional clinical trials:

(show top 50) (show all 3120)
# Name Status NCT ID Phase Drugs
1 Evaluation of Platelet Rich Fibrin Efficacy on Reduction of Periodontal Problems Unknown status NCT01583491 Phase 4
2 The Effect of Using Autologous Platelet Rich Plasma on Posterior Lumbar Interbody Fusion : a Randomized Comparative Trial Unknown status NCT03261843 Phase 4
3 Evaluating the Efficacy of Different Platelet Rich Plasma (PRP) Treatment Regimens in the Management of Androgenetic Alopecia: an Investigator-initiated, Single-center, Single-blinded, Prospective, Randomized Clinical Trial Unknown status NCT02999737 Phase 4
4 A 104-week, Open-label, Single-group Study: Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH) Unknown status NCT00885872 Phase 4 Rosuvastatin (Crestor)
5 Platelet Rich Fibrin in the Treatment of Palatal Wounds After Epithelialized Free Gingival Grafts Harvesting. A Randomized Clinical Trial Unknown status NCT02438046 Phase 4
6 Omega-3 Fatty Acids in First-episode Schizophrenia - a Randomized Controlled Study of Efficacy and Relapse Prevention (OFFER). Rationale, Design, and Methods. Unknown status NCT02210962 Phase 4
7 Irritation and Anal Bleeding in Patients Affected by Hemorrhoids: Comparative Evaluation of Three Different Treatments. Unknown status NCT03569930 Phase 4 flavonoid-based supplements;Centella Complex
8 Low Dose Calcium Supplementation to Prevent Preeclampsia: a Cluster Randomized Study Unknown status NCT02338687 Phase 4
9 Randomized, Parallel Groups, Multicenter and Blind to Evaluators Clinical Trial, to Evaluate the Efficacy and Safety of PRGF-Endoret Eye Drops, in Patients With Stage 2 and 3 Neurotrophic Keratitis Unknown status NCT02707120 Phase 4 PRGF-Endoret;Artificial tears eye-drops
10 An Open-label Switch Study to Asenapine in the Early Stage of Psychosis Unknown status NCT01968161 Phase 4 Asenapine
11 Comparative Study About the Impact of Two Oil Emulsions, One of Them Formulated With MCT, LCT, Olive Oil and Omega 3 Fatty Acids Versus Another One Formulated With MCT and LCT, Administered Intravenously on Severe Acute Pancreatitis Clinical Evolution Unknown status NCT01376817 Phase 4 Fat emulsion with MCT, LCT, olive oil and omega 3 fatty acids;Fat emulsion with MCT and LCT
12 Randomized Clinical Trial of Omega-3 Fatty Acid-supplemented Parenteral Nutrition Versus Standard Parenteral Nutrition in Patients Undergoing Major Laparoscopic Abdominal Surgery Unknown status NCT01819961 Phase 4 MCT/LCT and fish oil;MCT/LCT
13 Effect of Multi-vitamins With Minerals on Uric Acid Metabolism in Subjects With Hyperuricemia: A Randomized, Double-blinded, Placebo-controlled Trail Unknown status NCT03218709 Phase 4
14 Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine Unknown status NCT01840761 Phase 4 herbal drug;placebo
15 Adjusted Steroid Therapy in Children With Idiopathic Nephrotic Syndrome Unknown status NCT02649413 Phase 4 Prednisone
16 Insulin Requirement for Pure- Protein Meal in Children With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion - a Cross-over, Randomized Trial. Unknown status NCT02685449 Phase 4 Insulin glulisine;Insulin aspart;Insulin lispro
17 Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia - a Prospective, Randomized and Double Blinded Study. Unknown status NCT01509274 Phase 4
18 Phase 4 Study of Vitamin D3 Supplementation for Outcomes in Patients With Unipolar Depression Unknown status NCT01390662 Phase 4
19 Effect of Linagliptin on Intestinal Triglyceride-rich-lipoprotein Metabolism in Type 2 Diabetic Patients Unknown status NCT02280174 Phase 4 linagliptin
20 Prostatic Artery Embolization Versus 532 nm Green Light Laser Photoselective Vaporization of the Prostate for Treating Catheter-Dependent Patients With Benign Prostatic Hyperplasia: A Randomized Controlled Clinical Study Unknown status NCT02006303 Phase 4
21 Effects of a Chronical Treatment With Benfotiamine in People With Type 2 Diabetes Mellitus on Pre- and Postprandial Endothelial Function, as Well as on the Function of the Autonomic Nervous System Unknown status NCT00446810 Phase 4 Benfotiamine;Placebo
22 Pre-hYpertension tReament With A coMbinatIon of Dietary Supplements and Life-style Modifications Unknown status NCT01682291 Phase 4
23 Effect of Rosuvastatin Therapy on HDL2 Level and Antiatherosclerotic Reverse Cholesterol Transport Process in Chinses CAD Patients With Hyperlipidemia Unknown status NCT02593487 Phase 4 Rosuvastatin 10mg/d group;Rosuvastatin 20mg/d group
24 Artemether/ Lumefantrine: A Study of the Effect of Local Food on Pharmacokinetics of Lumefantrine and Population Pharmacokinetics of Lumefantrine Among Ugandan Children Unknown status NCT01944189 Phase 4
25 Effect of Iron Supplementation on Psychomotor Development of Non-anemic Exclusively or Predominantly Breastfed Infants: Randomized, Double-blind, Placebo-controlled Trial. Unknown status NCT02242188 Phase 4 Iron
26 Multicenter Study Evaluating the Efficacy of Dicopeg Junior in Comparison With Lactulose for the Treatment of Functional Constipation in Children Aged 6 Months to 6 Years. A Prospective, Randomized Study. Unknown status NCT03177434 Phase 4 polyethylene glycols (PEG) 3350;Lactulose Oral Product
27 Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome Unknown status NCT01951001 Phase 4 Prasugrel
28 A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SUPPLEMENTATION WITH KIOLIC® IN PATIENTS WITH DIAGNOSIS OF METABOLIC SYNDROME TO IMPROVE ENDOTHELIAL FUNCTION AND INFLAMMATORY STATE. "KYMES" Unknown status NCT01168700 Phase 4 aged garlic extract;Placebo
29 Functional Improvement and Ultrasound Tissue Characterisation of the Achilles Tendon Following Sodium Hyaluronate Injection for Plantaris Friction Syndrome Unknown status NCT03077009 Phase 4 Hyaluronic Acid
30 The ACT-OUT Trial: ACTivity OUTcomes Based on the Consumption of a High Carbohydrate or High Fat Diet in Patients With Metabolic Syndrome Unknown status NCT01357382 Phase 4
31 Effect of Platelet Rich Plasma ( PRP ) Applied During Knee Arthroscopy on Pain, Function and Quality of Life - A RCT With a Follow up of 12 Months Completed NCT02189408 Phase 4
32 Platelet Rich Plasma (PRP) in Total Knee Replacement: A Prospective, Randomized, Single-blind, Single-center Clinical Study to Evaluate the Effect of Platelet Rich Plasma (PRP) on Short-term Patient Outcomes Following Total Knee Replacement Completed NCT00826098 Phase 4
33 A Prospective Study to Analyze the Efficacy of IgM Rich Immunoglobulin as an Adjunct to Antibiotics in the Treatment of Bacterial Sepsis in Very Low Birth Weight Preterm Neonates Completed NCT03403530 Phase 4 IgM rich Immunoglobin
34 Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women. Completed NCT03444233 Phase 4
35 Intra-Articular Use of Platelet Rich Plasma Versus Corticosteroid: A Clinical Trials in Osteoarthritis of Knee. Completed NCT03086759 Phase 4 Triamcinolone Hexacetonide
36 Socket Augmentation Using Different Platelet Concentrates, Atorvastatin Gel or Combination (Clinical and Histomorphometric Study) Completed NCT03231137 Phase 4 ATV gel
37 Adjunctive Role of Platelets Rich Fibrin in Palatal Wound Healing After Free Gingival Graft Harvesting - Case Series Completed NCT02521467 Phase 4
38 Efficacy of Bone Marrow Aspirate Concentrate Compared With Platelet Rich Plasma for the Treatment of Symptomatic Knee Osteoarthritis: A Randomized, Controlled Clinical Trial Completed NCT03289416 Phase 4
39 Arthroscopic Rotator Cuff Repair Using Standard Double Row Technique With Platelet Rich Fibrin Membrane vs. Standard Double Row Technique: A Randomized Blinded Outcomes Study Completed NCT02256891 Phase 4
40 A Cohort Study to Evaluate the Effect of Vivostat Platelet Rich Fibrin on Diabetic Foot Ulcers. Completed NCT00770939 Phase 4
41 The Effect of Nitrate Supplementation: Source of Supplementation Completed NCT02271633 Phase 4
42 Regeneration of the Patellar Tendon After Harvesting Its Central Third With Platelet-rich Plasma. Prospective and Randomized Study. Completed NCT01111747 Phase 4
43 Pilot Study: Randomized Controlled Trial on the Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors Completed NCT00168987 Phase 4 oral nutritional supplement rich in eicosapentanoic acid
44 The Comparison of Knee Osteoarthritis Treatment With Single-dose of Bone Marrow Aspirate Concentrate, Single-dose of Leukocyte Rich Platelet Rich Plasma and 3 Injection of High Molecular Weight Hyaluronic Acid-A Randomized Clinical Trial Completed NCT03825133 Phase 4 Hyaluronic Acid
45 Plasma Rich in Growth Factors Effectiveness for Myofascial Pain Treatment in Masticatory Muscles: a Randomized Controlled Clinical Trial Completed NCT04040309 Phase 4 Lidocaine injection
46 Comparative Study Between Intra Articular Injection of Hyaluronic Acid (HA) With Platelet Rich Plasma (PRP) Versus Genicular Nerve Thermal Radiation in Management of Pain in Knee Osteoarthritis Completed NCT04188561 Phase 4 Intra articular injection Group
47 Socket Augmentation Using Atorvastatin With Or Without PRGF Derived Fibrin Scaffold (Clinical and Histomorphometric Study) Completed NCT03228771 Phase 4 PRGF/ATV;ATV gel
48 Effect of Onion Peel Extract on Endothelial Function and Endothelial Progenitor Cells in Overweight and Obese Subjects Completed NCT02180022 Phase 4 Placebo;Onion peel extract
49 'A Comparison of Platelet Rich Fibrin & Mineralised Freezed Dried Bone Allograft to Radiographically Evaluate Healing Post Endodontic Surgery'- an In-vivo Study Completed NCT04377698 Phase 4
50 Rosuvastatin 1.2mg in Situ Gel Combined With 1:1 Mixture of Autologous Platelet-rich Fibrin and Porus- Hydroxyappatite Bone Graft in Surgical Treatment of Mandibular Degree II Furcation Defects: A Randomized Clinical Control Trial Completed NCT02369250 Phase 4 Rosuvastatin

Search NIH Clinical Center for Rapidly Involuting Congenital Hemangioma

Sources

Genetic Tests for Rapidly Involuting Congenital Hemangioma

About this section
Sources

Anatomical Context for Rapidly Involuting Congenital Hemangioma

About this section

MalaCards organs/tissues related to Rapidly Involuting Congenital Hemangioma:

40
Bone, Liver, Breast, Skin, Endothelial, Brain, T Cells
Sources

Publications for Rapidly Involuting Congenital Hemangioma

About this section

Articles related to Rapidly Involuting Congenital Hemangioma:

(show top 50) (show all 30038)
# Title Authors PMID Year
1
Differential Expression Patterns of Rspondin Family and Leucine-Rich Repeat-Containing G-Protein Coupled Receptors in Chondrocytes and Osteoblasts. 61
32347037 2021
2
Positive effects of platelet-rich plasma (PRP) and a Sanguisorba officinalis polysaccharide on the proliferation and differentiation of anterior cruciate ligament (ACL) fibroblasts in vitro. 61
32252578 2020
3
Consumption of anthocyanin-rich beverages affects Nrf2 and Nrf2-dependent gene transcription in peripheral lymphocytes and DNA integrity of healthy volunteers. 61
32514500 2020
4
Synthesis and search for 3β,3'β-disteryl ethers after high-temperature treatment of sterol-rich samples. 61
32504917 2020
5
Therapeutic efficacy of platelet-rich plasma injection compared to corticosteroid injection in plantar fasciitis: A systematic review and meta-analysis. 61
32336895 2020
6
Changes in the quality of kefir fortified with anthocyanin-rich juices during storage. 61
32447161 2020
7
On the value of QSM from MPRAGE for segmenting and quantifying iron-rich deep gray matter. 61
32125012 2020
8
Revealing the variations in physicochemical, morphological, fractal, and rheological properties of digestate during the mesophilic anaerobic digestion of iron-rich waste activated sludge. 61
32334260 2020
9
Development and characterization of antioxidant and antimicrobial edible films based on chitosan and gamma-aminobutyric acid-rich fermented soy protein. 61
32536395 2020
10
Spirulina sp. LEB 18 cultivation in a raceway-type bioreactor using wastewater from desalination process: Production of carbohydrate-rich biomass. 61
32413641 2020
11
Remediation by waste marble powder and lime of jarosite-rich sediments from Portman Bay (Spain). 61
32438239 2020
12
Colloidal features of softwood galactoglucomannans-rich extract. 61
32507197 2020
13
Micro-analytical characterization of thorium-rich aggregates from Norwegian NORM sites (Fen Complex, Telemark). 61
32339145 2020
14
Antimicrobial polyphenol-rich extracts: Applications and limitations in the food industry. 61
32517896 2020
15
Feasibility of S-rich streams valorization through a two-step biosulfur production process. 61
32302909 2020
16
Qualitative and quantitative characterization of adsorption mechanisms for Cd2+ by silicon-rich biochar. 61
32402906 2020
17
A review on advanced catalytic co-pyrolysis of biomass and hydrogen-rich feedstock: Insights into synergistic effect, catalyst development and reaction mechanism. 61
32371033 2020
18
Edible flowers as a new source of natural antioxidants for oxidative protection of cold-pressed oils rich in omega-3 fatty acids. 61
32517952 2020
19
Characterization, bioavailability and protective effects of phenolic-rich extracts from almond hulls against pro-oxidant induced toxicity in Caco-2 cells. 61
32305872 2020
20
Potential of biogas production from manure of dairy cattle fed on natural soil supplement rich in iron under batch and semi-continuous anaerobic digestion. 61
32289655 2020
21
Multidimensional assembly of oxygen vacancy-rich amorphous TiO2-BiOBr-sepiolite composite for rapid elimination of formaldehyde and oxytetracycline under visible light. 61
32305729 2020
22
IgG4-rich reactive lymphoid hyperplasia of the lacrimal gland. 61
31724473 2020
23
Boron and nitrogen co-doped double-layered mesopore-rich hollow carbon microspheres as high-performance electrodes for supercapacitors. 61
32278954 2020
24
N-rich hydrochar derived from organic solvent as reaction medium generates toxic N-containing mineral in its pyrochar. 61
32388130 2020
25
Valorization of xylose-rich hydrolysate from rice straw, an agroresidue, through biosurfactant production by the soil bacterium Serratia nematodiphila. 61
32371209 2020
26
Two small, cysteine-rich and cationic antifungal proteins from Penicillium chrysogenum: A comparative study of PAF and PAFB. 61
32142818 2020
27
In vitro and in vivo anti-inflammatory activities of a fucose-rich fucoidan isolated from Saccharina japonica. 61
32289424 2020
28
Membrane pore-formation correlates with the hydrophilic angle of histidine-rich amphipathic peptides with multiple biological activities. 61
32057757 2020
29
Gasification of effluent from food waste treatment process in sub- and supercritical water: H2-rich syngas production and pollutants management. 61
32402957 2020
30
Sequential combination of nanofiltration and ettringite precipitation for managing sulfate-rich brines. 61
32474311 2020
31
Higher performers upregulate brain signal variability in response to more feature-rich visual input. 61
32283277 2020
32
The Prognostic Impact of Leucine-Rich α-2-Glycoprotein-1 in Cholangiocarcinoma and Its Association With the IL-6/TGF-β1 Axis. 61
32278969 2020
33
Diets naturally rich in polyphenols and/or long-chain n-3 polyunsaturated fatty acids differently affect microbiota composition in high-cardiometabolic-risk individuals. 61
32114641 2020
34
Anthocyanin-rich haskap (Lonicera caerulea L.) berry extracts reduce nitrosamine-induced DNA damage in human normal lung epithelial cells in vitro. 61
32413456 2020
35
Cyanidin-3-glucoside as a possible biomarker of anthocyanin-rich berry intake in body fluids of healthy humans: a systematic review of clinical trials. 61
31858139 2020
36
Membrane activity of two short Trp-rich amphipathic peptides. 61
32220553 2020
37
Association between protein-rich dietary patterns and anthropometric measurements among children aged 6 years. 61
32153120 2020
38
Microplastic identification and quantification from organic rich sediments: A validated laboratory protocol. 61
32163807 2020
39
Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration. 61
32247534 2020
40
New insights into the possible multiple roles of histidine-rich glycoprotein in blue mussels. 61
32298815 2020
41
Bio-conjugation of platelet-rich plasma and alginate through carbodiimide chemistry for injectable hydrogel therapies. 61
31846217 2020
42
Edible alginate/chitosan-based nanocomposite microspheres as delivery vehicles of omega-3 rich oils. 61
32414429 2020
43
An essential N-terminal serine-rich motif in the AAV VP1 and VP2 subunits that may play a role in viral transcription. 61
32452411 2020
44
Factors associated with positive outcomes of platelet-rich plasma therapy in Achilles tendinopathy. 61
32112184 2020
45
Second-Order Peer Reviews of Clinically Relevant Articles for the Physiatrist: Is Platelet-Rich Plasma Injection More Effective Than Corticosteroid for Treatment of Gluteal Tendinopathy? 61
31361618 2020
46
Cerebral infarction and iron deficiency anemia due to uterine myoma in two middle-aged women with histidine-rich glycoprotein deficiency. 61
32361514 2020
47
Beneficial effects of polysaccharide-rich extracts from Apocynum venetum leaves on hypoglycemic and gut microbiota in type 2 diabetic mice. 61
32361160 2020
48
Regulatory effect of Grifola frondosa extract rich in polysaccharides and organic acids on glycolipid metabolism and gut microbiota in rats. 61
31712147 2020
49
Nucleation of W-Rich Laves Phase Nanoparticles in Tempered Martensite Ferritic Steel During Long-Term Aging at Elevated Temperature. 61
31968503 2020
50
Comparison of two platelet rich plasma formulations with viscosupplementation in treatment of moderate grade gonarthrosis: A prospective randomized controlled study. 61
32071523 2020
Sources

Variations for Rapidly Involuting Congenital Hemangioma

About this section
Sources

Expression for Rapidly Involuting Congenital Hemangioma

About this section
Search GEO for disease gene expression data for Rapidly Involuting Congenital Hemangioma.
Sources

Pathways for Rapidly Involuting Congenital Hemangioma

About this section
Sources

GO Terms for Rapidly Involuting Congenital Hemangioma

About this section
Sources

Sources for Rapidly Involuting Congenital Hemangioma

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....